New patient guidelines for heart devices

April 17, 2011

A series of new guidelines for cardiac specialists has been developed to determine when heart failure patients should receive a mechanical heart-pumping device.

"The new guidelines will likely affect who is referred for a mechanical circulatory support device, and how early in the process a physician would consider implanting a left ," says Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory Support at Henry Ford Hospital. "These guidelines have the ability to change clinical practice patterns for patients with advanced ."

Dr. Morgan will present the guidelines Saturday, April 16 at the International Society of Heart and Lung Transplantation (ISHLT) annual meeting in San Diego.

The left ventricular assist device (LVAD) is a battery-operated pumping device, surgically implanted to help a weakened blood.

Last year, approximately 2500 LVADs were implanted nationally, which is used chiefly for patients waiting for a heart transplant due to the chronic donor shortage. In other cases, it is used for long-term support in patients who are not eligible for a .

Dr. Morgan played a leadership role in the formation of the ISHLT's Mechanical Circulatory Support Council that authored the guidelines, due to the high-quality, high-volume LVAD implant program at Henry Ford. The program has a growing national reputation in clinical, academic and research areas.

Explore further: Non-cardiac surgery: Safe for patients with heart device

Related Stories

Recommended for you

An accessible approach to making a mini-brain

October 1, 2015

If you need a working miniature brain—say for drug testing, to test neural tissue transplants, or to experiment with how stem cells work—a new paper describes how to build one with what the Brown University authors say ...

Tension helps heart cells develop normally in the lab

October 1, 2015

The heart is never quite at rest, and it turns out that even in a lab heart cells need a little of that tension. Without something to pull against, heart cells grown from stem cells in a lab dish fail to develop normally.

Dormant viral genes may awaken to cause ALS

September 30, 2015

Scientists at the National Institutes of Health discovered that reactivation of ancient viral genes embedded in the human genome may cause the destruction of neurons in some forms of amyotrophic lateral sclerosis (ALS). The ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.